Scaled Microbiomics is a biotech company developing immunotherapeutic approaches to modifying human and animal microbiomes. Our patented technology platform targets microorganisms that contribute to microbiome imbalance, or dysbiosis, to reduce the risk and impact of a broad range of health conditions now recognized to have strong microbiome associations both within and outside of the gastrointestinal tract.